Ep. 741 - What Can Doom Your Implants? Uncovering the Risks of Implant Failure

With millions of dental implants placed annually and patients living longer than ever, are we prepared for the growing challenge of peri-implantitis? How do we balance patient expectations with emerging standards of care that could fundamentally change implant practice?

Dr. Jon Suzuki brings unparalleled expertise to this critical discussion. A Presidential Appointee Professor of Microbiology and Immunology at Temple University School of Medicine and Professor of Periodontology and Oral Implantology, Dr. Suzuki has served as former Dean at the University of Pittsburgh, Chairman of the FDA Dental Products Panel, and Chairman of the ADA Council on Scientific Affairs. He holds a D.D.S. from Loyola University, Ph.D. in Microbiology from Illinois Institute of Technology, completed NIH Fellowship in Immunology, earned Clinical Certificate in Periodontics from University of Maryland, and holds an MBA from University of Pittsburgh. A Diplomate of the American Board of Periodontology and Fellow of the American and International College of Dentists, he has published over 150 papers and continues active hospital practice.

This episode addresses the multifaceted challenges of long-term implant success, examining both patient responsibilities and evolving clinical standards. The discussion explores how systemic medications commonly prescribed to aging populations may significantly impact implant outcomes, while questioning whether current diagnostic protocols meet the demands of contemporary implant dentistry.

Episode Highlights:

• Patient education must occur before implant placement, emphasizing quarterly recalls, optimized oral hygiene protocols, and continuous medical history updates. The restorative dentist bears greater responsibility for ongoing clinical surveillance and maintenance when managing implanted patients, requiring elevated standards compared to natural dentition care.
• CBCT imaging should be considered the current minimum standard of care for any dental implant placement, with monitoring requirements extending to the restorative phase every three to five years. Legal precedent through increasing malpractice cases against dentists not utilizing CBCT will likely drive universal adoption of this imaging standard.
• Oral bisphosphonates present significant risk factors following a three-year exposure threshold, with intravenous formulations carrying tenfold higher risks for anti-resorptive osteonecrosis of the jaw. Treatment planning must incorporate medical consultation and specialized consent protocols when invasive procedures are considered beyond this timeline.
• Proton pump inhibitors, used by 20-25% of patients over 50, disrupt calcium absorption mechanisms and increase hip fracture risk by 2.5 times after one year of use. These medications compromise bone homeostasis through gastric pH alteration, potentially affecting long-term implant success through impaired calcium metabolism.
• Peri-implant mucositis presents with circumferential gingival erythema and bleeding upon probing, similar to gingivitis but requiring more aggressive intervention. This reversible condition should resolve within three months of proper treatment, but persistent cases warrant deeper scaling, antimicrobial irrigation, and local drug delivery systems before progression to irreversible peri-implantitis.

Perfect for: General dentists placing or restoring implants, periodontists, oral surgeons, and dental hygienists managing implant patients. Particularly valuable for clinicians treating aging populations with complex medical histories.

This evidence-based discussion will reshape how you approach implant treatment planning and long-term patient care.